Nothing Special   »   [go: up one dir, main page]

FI10194U1 - Setilistaattia sisältäviä koostumuksia - Google Patents

Setilistaattia sisältäviä koostumuksia

Info

Publication number
FI10194U1
FI10194U1 FIU20124262U FIU20124262U FI10194U1 FI 10194 U1 FI10194 U1 FI 10194U1 FI U20124262 U FIU20124262 U FI U20124262U FI U20124262 U FIU20124262 U FI U20124262U FI 10194 U1 FI10194 U1 FI 10194U1
Authority
FI
Finland
Prior art keywords
cetilate
compositions containing
compositions
formulations
relates
Prior art date
Application number
FIU20124262U
Other languages
English (en)
Swedish (sv)
Inventor
John Robert Bloor
Christopher Robert Dunk
Richard Michael John Palmer
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122213.0A external-priority patent/GB201122213D0/en
Priority claimed from GBGB1203082.1A external-priority patent/GB201203082D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Application granted granted Critical
Publication of FI10194U1 publication Critical patent/FI10194U1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manipulation Of Pulses (AREA)
  • Logic Circuits (AREA)
FIU20124262U 2011-12-23 2012-12-20 Setilistaattia sisältäviä koostumuksia FI10194U1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1122213.0A GB201122213D0 (en) 2011-12-23 2011-12-23 Compositions
GBGB1203082.1A GB201203082D0 (en) 2012-02-22 2012-02-22 Compositions

Publications (1)

Publication Number Publication Date
FI10194U1 true FI10194U1 (fi) 2013-08-20

Family

ID=47560448

Family Applications (1)

Application Number Title Priority Date Filing Date
FIU20124262U FI10194U1 (fi) 2011-12-23 2012-12-20 Setilistaattia sisältäviä koostumuksia

Country Status (8)

Country Link
AU (1) AU2012101841A4 (fi)
DK (1) DK201200198Y4 (fi)
ES (1) ES2417408B1 (fi)
FI (1) FI10194U1 (fi)
FR (1) FR2984745B3 (fi)
IE (1) IES86183B2 (fi)
IT (1) ITTO20121118A1 (fi)
NL (1) NL2009995C2 (fi)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
JP5044398B2 (ja) * 2005-06-09 2012-10-10 武田薬品工業株式会社 固形製剤
JP2010254623A (ja) * 2009-04-24 2010-11-11 Takeda Chem Ind Ltd ベンゾオキサジノン化合物の結晶

Also Published As

Publication number Publication date
FR2984745B3 (fr) 2017-12-22
NL2009995A (en) 2013-06-26
NL2009995C2 (en) 2013-09-18
FR2984745A3 (fr) 2013-06-28
DK201200198Y4 (da) 2018-09-17
DK201200198U1 (en) 2013-04-12
AU2012101841A4 (en) 2013-01-17
ITTO20121118A1 (it) 2013-06-24
ES2417408B1 (es) 2014-11-26
ES2417408A2 (es) 2013-08-07
IES20120556A2 (en) 2013-05-08
IES86183B2 (en) 2013-05-08
ES2417408R1 (es) 2013-10-15

Similar Documents

Publication Publication Date Title
CY1119762T1 (el) C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτων
NZ706739A (en) Substituted benzene compounds
EA201500652A1 (ru) Дифторметилникотиновые инданилкарбоксамиды
EA201490357A1 (ru) Индазолы
PH12014502697A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
IN2014MN02106A (fi)
IN2014MN02598A (fi)
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
PH12015501609A1 (en) Phenicol antibacterials
CR20140135A (es) Nuevos derivados de aril-quinolina
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
EA201490037A1 (ru) Антагонисты trpv4
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
IN2014CN01216A (fi)
CL2013003056A1 (es) Compuestos derivados de (fenil o piridin)-etinil-(piridin o pirimidin) sustituido; composición farmacéutica que los comprende; proceso de preparación de esto; y su uso en el tratamiento de la esquizofrenia o enfermedades cognitivas.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
UY33528A (es) Derivados de oxadiazoles y de piridazinas, su preparacion y su aplicacion en terapeutica
IN2014CN01217A (fi)
IN2015DN02109A (fi)
MX365429B (es) Formulacion de aroma y fragancia (i).
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
EA201390488A1 (ru) Новые агонисты gpr 119
EA201590846A1 (ru) Клизмы
MX2015005312A (es) Derivados de 1h-indazol-3-carboxamida y uso de los mismos como antagonistas de p2y12.
MY166057A (en) Carbocyclic nucleosides and their pharmaceutical use and compositions

Legal Events

Date Code Title Description
FGU Utility model registered

Ref document number: 10194

Country of ref document: FI

Kind code of ref document: U1

MMU Utility model lapsed